Evidence map›Paper›PMID 36410708›Full record

ArticleOphthalmology. Glaucoma

Deep Learning-Assisted Detection of Glaucoma Progression in Spectral-Domain OCT.

Eduardo B Mariottoni, Shounak Datta, Leonardo S Shigueoka, Alessandro A Jammal, Ivan M Tavares, Ricardo Henao, Lawrence Carin, Felipe A Medeiros

Abstract read
In one paragraph

Article in Ophthalmology. Glaucoma. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Artificial Intelligence in Glaucoma Detection and Progression.Advances in ophthalmology and optometry · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eduardo B MariottoniVision, Imaging, and Performance (VIP) Laboratory, Duke Eye Center, Duke University, Durham, North Carolina; Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.
Shounak DattaDepartment of Electrical and Computer Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina.
Leonardo S ShigueokaVision, Imaging, and Performance (VIP) Laboratory, Duke Eye Center, Duke University, Durham, North Carolina.
Alessandro A JammalVision, Imaging, and Performance (VIP) Laboratory, Duke Eye Center, Duke University, Durham, North Carolina.
Ivan M TavaresDepartment of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.
Ricardo HenaoDepartment of Electrical and Computer Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina.
Lawrence CarinDepartment of Electrical and Computer Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina.
Felipe A MedeirosVision, Imaging, and Performance (VIP) Laboratory, Duke Eye Center, Duke University, Durham, North Carolina; Department of Electrical and Computer Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina. Electronic address: felipe.medeiros@duke.edu.

Funding

The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in GlaucomaR01EY029885 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ASRANI, SANJAY, MEDEIROS, FELIPE · 2019 to 2022
$2.2M
Objective Quantification of Neural Damage for Screening, Diagnosis and Monitoring of Glaucoma with Fundus PhotographsR21EY031898 · NEI · DUKE UNIVERSITY · PI MEDEIROS, FELIPE · 2020 to 2021
$437k
NEI NIH HHS R01 EY029885NEI NIH HHS R21 EY031898
6 · The paper itself

Abstract

purposeTo develop and validate a deep learning (DL) model for detection of glaucoma progression using spectral-domain (SD)-OCT measurements of retinal nerve fiber layer (RNFL) thickness.

designRetrospective cohort study.

participantsA total of 14 034 SD-OCT scans from 816 eyes from 462 individuals.

methodsA DL convolutional neural network was trained to assess SD-OCT RNFL thickness measurements of 2 visits (a baseline and a follow-up visit) along with time between visits to predict the probability of glaucoma progression. The ground truth was defined by consensus from subjective grading by glaucoma specialists. Diagnostic performance was summarized by the area under the receiver operator characteristic curve (AUC), sensitivity, and specificity, and was compared with conventional trend-based analyses of change. Interval likelihood ratios were calculated to determine the impact of DL model results in changing the post-test probability of progression.

main outcome measuresThe AUC, sensitivity, and specificity of the DL model.

resultsThe DL model had an AUC of 0.938 (95% confidence interval [CI], 0.921-0.955), with sensitivity of 87.3% (95% CI, 83.6%-91.6%) and specificity of 86.4% (95% CI, 79.9%-89.6%). When matched for the same specificity, the DL model significantly outperformed trend-based analyses. Likelihood ratios for the DL model were associated with large changes in the probability of progression in the vast majority of SD-OCT tests.

conclusionsA DL model was able to assess the probability of glaucomatous structural progression from SD-OCT RNFL thickness measurements. The model agreed well with expert judgments and outperformed conventional trend-based analyses of change, while also providing indication of the likely locations of change. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Indexed as

Deep LearningGlaucomaOptic DiskHumansRetinal Ganglion CellsRetrospective StudiesTomography, Optical CoherenceVisual FieldsArtificial intelligenceDeep learningGlaucomaOCTProgression

Identifiers

PMID36410708
PMCPMC10278200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.